• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Industrials·4163.TWO
Share

INTAI Technology Corporation Stocks

NT$ 123.5Last Updated 24.07.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

NT$ 191.84M

NT$ 123.5
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

INTAI Technology Corporation, established in 1988 and headquartered in Taichung, Taiwan, is a diversified manufacturer. The company specializes in providing a broad spectrum of products to various sectors, including automotive, aerospace, precision hardware, medical devices, and electronic communication, serving both the Taiwanese domestic market and international clients. Its extensive product portfolio features both standard and custom-engineered precision hardware components. INTAI also dedicates a significant portion of its expertise to the medical field, manufacturing critical components for applications like endoscopic minimally invasive surgery, breast biopsy devices, and a wide array of disposable and reusable medical instruments. Furthermore, the company develops and supplies a comprehensive range of orthopedic implants, such as thoracolumbar and cervical spinal sets, pedicle screws, PEEK and titanium cages, trauma screws and plates, and specialized surgical instruments. Beyond these, INTAI extends its capabilities to offer RF and microwave products, catering to commercial, wireless, automotive, and telecommunication industries.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITDA, trading

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of 4163.TWO is 114 and suggests 9.16% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation t

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.07.2026 16:22

AI chips, smuggling, and a hair dryer: What the Supermicro scandal reveals about the U.S.-China rivalry

24.07.2026 15:54

Shutterstock's stock plummeted to a record low. The company will suspend dividend payments.

24.07.2026 15:30

Morning in New York: The news flow will set the tone for trading

24.07.2026 15:15

Google has disclosed its investments in SpaceX and Anthropic. Why is an analyst calling it an “illusion”?

24.07.2026 14:59

IPO Scribe: Shares in a biotech company backed by Eli Lilly and Sanofi are now available

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026